CCCC

NASDAQ · Equity

C4 Therapeutics Inc

US Healthcare Biotechnology

Latest week
29 May 2026
Close
4.370000
Fair value
3.710705
Expectation
Negative 40.94%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
4.37
12-Week Change
60.66%
Trend Signal
Active
Expectation
Negative 40.94%
Signal Weeks
8 of 12
Vs Trend Line
Above
Vs Fair Value
Above
Relative Strength
47.04
Market Dynamics
1.21

Over the latest 12 completed weeks ending 2026-05-29, CCCC rose 60.66%, moving from 2.72 to 4.37. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 8 of the last 12 weeks. Relative Strength is 47.04 and has improved across the 12-week window. Market Dynamics is 1.21 on the latest week. Expectation is negative at 40.94%.